Filed in archive, on May 21, 2007
A -like dietary supplement, N-acetylglucosamine (GlcNAc), has been found to suppress the damaging autoimmune response observed in multiple sclerosis and type 1 diabetes mellitus.
In studies on mice, Dr. Michael Demetriou and colleagues with the UC Irvine Center for Immunology found that N-acetylglucosamine (GlcNAc), which is similar but more effective than the widely available glucosamine, inhibited the growth and function of abnormal T-cells that incorrectly direct the immune system to attack specific tissues in the body, such as brain myelin in MS and insulin-producing cells of the pancreas in diabetes.
Together with a recent study on the use of GlcNAc in the treatment of treatment-resistant autoimmune inflammatory bowel disease, these findings point to the use of metabolic therapy using dietary supplements such as GlcNAc for treating autoimmune diseases.
More details from UC Irvine.
Tags: multiple+sclerosis diabetes acetylglucosamine dietary+supplement autoimmune+disease biotech biotech+
Rating: 9.08 out of 12 vote(s) cast.
Response from: (05/31/07 7:56am)
Response from:(06/13/07 11:06am)
Response from:(06/27/07 7:13pm)
Response from:(09/24/07 5:22am)
Response from:(09/26/07 12:29pm)
Response from:(06/15/09 3:25am)